Acute administration of the GLP-1 receptor agonist lixisenatide diminishes postprandial insulin secretion in healthy subjects but not in type 2 diabetes, associated with slowing of gastric emptying
doi: 10.1002/hep.32612 89 YanGWangXSunCZhengXWeiHTianZet al
Neural regeneration research, 17(3), 482487
Study results Of the 3,417 randomized adults, 2,108 received the drug combination, 302 received semaglutide, 302 received cagrilintide, and 705 received a placebo
Y., Wada, S., Sato, K., & Higashi, A
Overexpressing the mutated fas1 R1834K increased the production of medium-chain fatty acids (C8C12) and resulted in an MLM content of 0.41 mol% of the total TAGs